Amid continued escalations in the Middle East conflict, the Indian government is considering a temporary price hike between 10 and 15 percent for essential medicines, according to a media report. The surge in prices for select medicines could lead to higher drug prices but potentially benefit Indian pharmaceutical manufacturers facing the brunt of the Iran war. “The immediate net consumer impact could be 3-5 percent higher prices, or roughly similar to what consumers paid before the late-September cuts in GST rates,” said the report by Economic Times, citing top industry executives aware of the government’s discussions. The proposal was reportedly floated after several top drugmakers raised concerns about the sharp increase in prices of solvents and active pharmaceutical ingredients (APIs) due to global supply disruptions. The price hike is expected to remain for up to four months and will be rolled back once the input cost stabilizes, the report said. Further, it cited a senior government official saying that they have received the industry proposal for a price hike, but the decision to implement depends "on how long the geopolitical tension in West Asia lasts". Increasing Raw Material Costs Drive Up Medical Device Prices HealthandMe had earlier reported that the ongoing conflict has already spiked prices for medical devices—specifically plastics for syringes and catheters—due to the rising cost of raw materials. If disruptions persist, it can also warn of potential shortages. “A shortage of liquid helium could impact the installation of new MRI scanners, each of which requires around 1,500 liters for the initial magnet fill. Supply disruptions linked to the war may delay new installations and push up costs, as helium prices are likely to rise amid tighter availability,” Dr. Harsh Mahajan, Mentor FICCI & Founder Mahajan Imaging & Labs, told HealthandMe. The expert noted that there is no immediate concern for existing MRI machines. It is because most currently installed scanners use K4 technology with zero boil-off systems, allowing them to operate efficiently without frequent helium refills. “Typically, a top-up is needed only once every three years, when the magnet’s cold head is replaced. As a result, the existing installed base is expected to continue functioning without disruption in the near term,” Dr. Mahajan said. Also read: Report Claims Mojtaba Khamenei ‘Incapacitated’: What Does This Mean MedicallyLong-term Hormuz Blockade Can Affect Critical Medical Supplies However, the rapidly deteriorating situations and a longer blockade of Hormuz can lead to “substantial price increases, longer lead times, and highly elevated freight costs, which are pressuring cost structures and planning cycles”. According to Rajiv Nath, AiMeD, the evolving global supply chain dynamics require close monitoring to prevent impacts on production timelines and industry stability. The Medical Technology Association of India (MTaI) also warned that the ongoing US/Israel-Iran conflict and disruption in the Strait of Hormuz directly threaten India’s access to critical and life-saving medical technologies. "Modern healthcare systems operate on just-in-time inventory models with minimal buffer stock. When large consignments - like those shipped by sea - are delayed or stranded, there is simply not enough inventory in the system to compensate, even through costlier alternatives like air freight," Pavan Choudary, Chairman, MTaI, told HealthandMe. He also noted that shipment delays beyond March 31 can lead to "budget lapse, forcing a fresh approval cycle - thereby compounding delays that often stretch to months". It is because many public institutions in India front-load procurement toward the financial year-end.